FACULTY
Managing Cardiovascular Risk: Special Considerations in Patients with Chronic Kidney Disease
Paper Symposium
Activity Date: July 2005  — Activity Info: Volume 5, (7A)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

Full Disclosure Policy Affecting CME Activities:
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTORS

Mohamed G. Atta, MD, MPH
Assistant Professor of Medicine
Division of Nephrology
Johns Hopkins University
School of Medicine
Baltimore, Maryland
Dr Atta reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Norman Lepor, MD, FACC, FAHA
Associate Clinical Professor of Medicine
David Geffen School of Medicine at the University of California, Los Angeles
Attending Cardiologist
Cedars-Sinai Medical Center
Los Angeles, California
Dr Atta reports having no significant financial or advisory relationships with corporate organizations related to this activity.

PARTICIPATING FACULTY

Anil Agarwal, MD, FACP, FASN
Associate Professor of Clinical Medicine
Ohio State University
Columbus, Ohio
Dr Agarwal reports having no significant financial or advisory relationships with corporate organizations related to this activity.

Jeffrey S. Berns, MD
Associate Professor of Medicine
Renal, Electrolyte, and Hypertension Division
University of Pennsylvania
Philadelphia, Pennsylvania
Dr Berns reports receiving grants/research support from Amgen Inc and Ortho Biotech Products, LP, and serving as a consultant to and receiving honoraria from Amgen Inc.

Jeffrey Brinker, MD
Professor of Medicine
Division of Cardiology
Johns Hopkins Hospital
Baltimore, Maryland
Dr Brinker reports receiving grants/research support from Amgen Inc and Ortho Biotech Products, LP; and receiving honoraria from Amgen Inc.

Steven Fishbane, MD
Director, Dialysis Service
Associate Director
Division of Nephrology
Associate Chairman
Department of Medicine
Winthrop University Hospital
Mineola, New York
Dr Fishbane reports receiving grants/research support from Amgen Inc and Ortho Biotech Products, LP; and receiving honoraria from Amgen Inc.

Paul J. Scheel, Jr, MD
Vice Chairman
Department of Medicine
Clinical Director
Division of Nephrology
Johns Hopkins Hospital
Baltimore, Maryland
Dr Scheel reports holding stock in Amgen Inc.

Notice: The authors have indicated that this CE activity contains no mention of unlabeled/unapproved uses of drugs or devices.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?